David Bourget (Western Ontario)
David Chalmers (ANU, NYU)
Rafael De Clercq
Jack Alan Reynolds
Learn more about PhilPapers
Developing World Bioethics 4 (1):42–57 (2004)
ABSTRACTAccording to some estimates, less than 10% of the world's biomedical research funds are dedicated to addressing problems that are responsible for 90% of the world's burden of disease. This paper explains why this disparity exists and what should be done about it. It argues that the disparity exists because: 1) multinational pharmaceutical and biotechnology companies do not regard research and development investments on the health problems of developing nations to be economically lucrative; and 2) governmental agencies that sponsor biomedical research face little political pressure to allocate funds for the problems of developing nations. This paper argues that developed nations have an obligation to address disparities related to biomedical research funding. To facilitate this effort, developed countries should establish a trust fund dedicated to research on the health problems of developing nations similar to the Global AIDS Fund
|Keywords||No keywords specified (fix it)|
|Categories||categorize this paper)|
Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
|Through your library|
References found in this work BETA
Charles R. Beitz (2000). Rawls's Law of Peoples. Ethics 110 (4):669-696.
Udo Schüklenk & Richard E. Ashcroft (2002). Affordable Access to Essential Medication in Developing Countries: Conflicts Between Ethical and Economic Imperatives. Journal of Medicine and Philosophy 27 (2):179 – 195.
David B. Resnik (2001). Developing Drugs for the Developing World: An Economic, Legal, Moral, and Political Dilemma. Developing World Bioethics 1 (1):11-32.
Dan W. Brock (2001). Some Questions About the Moral Responsibilities of Drug Companies in Developing Countries. Developing World Bioethics 1 (1):33-37.
Udo Schüklenk (2002). Affordable Access to Essential Medication in Developing Countries: Conflicts Between Ethical and Economic Imperatives1. Journal of Medicine and Philosophy 27 (2):179-195.
Citations of this work BETA
Geoffrey Lairumbi, Michael Parker, Raymond Fitzpatrick & Michael English (2012). Forms of Benefit Sharing in Global Health Research Undertaken in Resource Poor Settings: A Qualitative Study of Stakeholders' Views in Kenya. Philosophy, Ethics, and Humanities in Medicine 7 (1):1-8.
Jantina de Vries, Susan J. Bull, Ogobara Doumbo, Muntaser Ibrahim, Odile Mercereau-Puijalon, Dominic Kwiatkowski & Michael Parker (2011). Ethical Issues in Human Genomics Research in Developing Countries. BMC Medical Ethics 12 (1):5.
Shawn H. E. Harmon (2006). Solidarity: A (New) Ethic for Global Health Policy. [REVIEW] Health Care Analysis 14 (4):215-236.
Michael J. Selgelid (2007). Ethics and Drug Resistance. Bioethics 21 (4):218–229.
Inmaculada de Melo-Martín & Kristen Intemann (2011). Feminist Resources for Biomedical Research: Lessons From the HPV Vaccines. Hypatia 26 (1):79-101.
Similar books and articles
Alex John London (2005). Justice and the Human Development Approach to International Research. Hastings Center Report 35 (1):24-37.
Bridget Pratt & Bebe Loff (2011). Justice in International Clinical Research. Developing World Bioethics 11 (2):75-81.
Bridget Pratt & Bebe Loff (2013). Linking International Research to Global Health Equity: The Limited Contribution of Bioethics. Bioethics 27 (4):208-214.
Iii Holmes Rolston (1995). Environmental Protection and an Equitable International Order. Business Ethics Quarterly 5 (4):735-752.
David B. Resnik (2001). Setting Biomedical Research Priorities: Justice, Science, and Public Participation. Kennedy Institute of Ethics Journal 11 (2):181-204.
Shawna Gutfreund, Doing Justice Justice : Distinguishing Social Justice From Distributive Justice and the Implications for Bioethics.
Christopher Tollefsen (2008). Biomedical Research and Beyond: Expanding the Ethics of Inquiry. Routledge.
Annette Rid & David Wendler (2011). A Framework for Risk-Benefit Evaluations in Biomedical Research. Kennedy Institute of Ethics Journal 21 (2):141-179.
Malhar N. Kumar (2008). A Review of the Types of Scientific Misconduct in Biomedical Research. [REVIEW] Journal of Academic Ethics 6 (3):211-228.
Added to index2009-01-28
Total downloads13 ( #194,523 of 1,726,249 )
Recent downloads (6 months)1 ( #369,877 of 1,726,249 )
How can I increase my downloads?